Skip to content
Inciteful Med

Symptoms and Diagnosis of SFT

Last updated:

Solitary Fibrous Tumor (SFT) is diagnosed through a combination of imaging and pathology. Symptoms vary by location but often involve "mass effect" pressure on organs. A rare complication called Doege-Potter Syndrome can cause dangerous low blood sugar. Definitive diagnosis requires a biopsy confirming nuclear STAT6 protein expression.

Key Takeaways

  • • SFT symptoms are primarily caused by the 'mass effect' of the tumor pressing on surrounding organs.
  • • Doege-Potter Syndrome is a rare but critical warning sign involving severe hypoglycemia (low blood sugar).
  • • Imaging scans often show 'flow voids' or intense enhancement, indicating the tumor is rich in blood vessels.
  • • The definitive diagnosis requires a biopsy confirming nuclear STAT6 protein expression.

Diagnosing a Solitary Fibrous Tumor (SFT) is often a multi-step process. Because these tumors are rare and can look like many other types of growths on a scan, doctors must combine your symptoms, specialized imaging, and advanced laboratory testing to reach a definitive diagnosis.

Symptoms: The “Mass Effect”

The symptoms of SFT usually depend on where the tumor is growing and how much pressure it is putting on surrounding organs—this is known as the mass effect [1][2].

  • Chest (Pleura): Many patients have no symptoms at first. As the tumor grows, it can cause a persistent cough, chest pain, or dyspnea (shortness of breath) [3][4].
  • Brain and Spine (CNS): Tumors in these areas often mimic more common growths like meningiomas. They can cause headaches, seizures, or focal neurological deficits, such as weakness or numbness in the arms or legs [5][6].
  • Soft Tissues: Symptoms vary widely based on location. For example, a tumor in the eye socket (orbit) might cause a bulging eye or vision changes, while one in the abdomen might cause a feeling of fullness or urinary issues [1][7].

Doege-Potter Syndrome: A Critical Warning

In a small number of cases (less than 5%), SFTs can cause a rare condition called Doege-Potter Syndrome (DPS) [8][9]. This occurs when the tumor releases a protein called “big” IGF-2, which mimics insulin and causes dangerously low blood sugar (hypoglycemia) [10][11].

Symptoms of DPS:

  • Severe dizziness or confusion
  • Profuse sweating
  • Loss of consciousness
  • Symptoms improve immediately after eating sugar

SAFETY ALERT: If you experience these symptoms, seek medical attention immediately. Severe hypoglycemia can be life-threatening. You may need to eat frequent small meals or take medication to manage your blood sugar while waiting for surgery [12]. Surgically removing the tumor usually cures this condition immediately [13].

Imaging: Seeing the Tumor

Doctors use CT scans and MRI to look for clues that a growth might be an SFT. While imaging alone cannot prove a tumor is an SFT, certain “red flags” suggest it:

  • Hypervascularity: SFTs are typically rich in blood vessels. On scans, this shows up as intense “enhancement” when contrast dye is used [14][15].
  • Flow Voids: In the brain or eye socket, radiologists often see “flow voids”—dark lines on an MRI. These lines represent blood moving so fast through the tumor’s vessels that the MRI scanner captures it as a void or blank space [15][16].
  • Mixed Signals: SFTs often show a mix of solid and fibrous areas, which can create a “patchy” appearance on an MRI [14][17].

Pathology: The Gold Standard

The only way to confirm an SFT diagnosis is through a biopsy or surgical removal, followed by a detailed review by a pathologist [18].

The “gold standard” test is STAT6 Immunohistochemistry (IHC) [19][20]. The pathologist applies a special stain to the tumor sample; if the STAT6 protein moves into the nucleus (the command center) of the cells, it confirms the presence of the NAB2-STAT6 gene fusion—the defining genetic hallmark of SFT [21][22]. This test is highly accurate and helps distinguish SFT from many other tumors that look similar under a microscope [19][23].

Frequently Asked Questions

What are the common symptoms of a Solitary Fibrous Tumor?
SFT symptoms depend on where the tumor is located. Common signs include cough or shortness of breath for chest tumors, and headaches or seizures for tumors in the brain or spine. Some patients may feel pressure or see a visible bulge in soft tissue areas like the eye socket.
What is Doege-Potter Syndrome?
Doege-Potter Syndrome is a rare condition affecting less than 5% of SFT patients where the tumor releases a protein that mimics insulin. This causes dangerously low blood sugar (hypoglycemia), leading to dizziness, confusion, and loss of consciousness. It is usually cured by surgically removing the tumor.
How do doctors confirm an SFT diagnosis?
The gold standard for diagnosing SFT is a pathology test called STAT6 Immunohistochemistry. If the STAT6 protein is found in the nucleus of the tumor cells, it confirms the presence of the gene fusion specific to SFT, distinguishing it from other similar-looking tumors.
What does an SFT look like on an MRI or CT scan?
On an MRI, SFTs often appear "hypervascular," meaning they are rich in blood vessels. Radiologists may look for "flow voids"—dark lines that represent blood moving quickly through the tumor. These visual clues suggest SFT but cannot prove it without a biopsy.

Questions for Your Doctor

  • • Does my pathology report specifically confirm the presence of nuclear STAT6 expression?
  • • Was my tumor hypervascular (rich in blood vessels) on imaging, and how does that affect my surgical plan?
  • • If my tumor is in the brain or spine, are there signs of 'skull invasion' or 'blurred interfaces' that could affect my risk of recurrence?
  • • Should I be monitored for symptoms like low blood sugar (Doege-Potter Syndrome), and what blood tests would track that?
  • • How did my imaging (CT or MRI) help distinguish this tumor from more common growths like meningiomas?

Questions for You

  • • Have you experienced any persistent headaches, seizures, or unexplained weakness in your limbs?
  • • Do you have a frequent cough or feel short of breath even when resting?
  • • Have you noticed any episodes of dizziness, sweating, or confusion that seem to go away after eating something sugary?
  • • Is the area where your tumor was found causing you any physical pain or pressure?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Solitary Fibrous Tumor of the Orbit: A Case Report and Review of the Literature.

    Genc A, Toktas Z, Azman C, et al.

    Turkish neurosurgery 2015; (25(6)):984-7 doi:10.5137/1019-5149.JTN.11183-14.1.

    PMID: 26617156
  2. 2

    Solitary Fibrous Tumor of the Vulva: Case Report of a Rare Entity and Review of Literature.

    Tandon N

    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2021; (40(3)):234-239 doi:10.1097/PGP.0000000000000707.

    PMID: 32925444
  3. 3

    Intrathoracic giant solitary fibrous tumor of the pleura: Case report.

    Mindaye ET, Tesfaye GK, Aboye AG

    International journal of surgery case reports 2021; (85()):106224 doi:10.1016/j.ijscr.2021.106224.

    PMID: 34311340
  4. 4

    Intrapulmonary cavitating solitary fibrous tumor: A rare case report.

    Kusumaningrum DW, Hayati F

    Radiology case reports 2025; (20(1)):228-233 doi:10.1016/j.radcr.2024.09.129.

    PMID: 39507435
  5. 5

    Diagnosis and treatment of solitary fibrous tumor/hemangiopericytoma of central nervous system. Retrospective report of 17 patients and literature review.

    Ma L, Wang L, Fang X, et al.

    Neuro endocrinology letters 2018; (39(2)):88-94.

    PMID: 30183202
  6. 6

    Spinal Intramedullary Solitary Fibrous Tumor: A Rare and Challenging Diagnosis.

    Yang C, Xu Y, Liu X

    Cancer management and research 2019; (11()):10321-10326 doi:10.2147/CMAR.S231019.

    PMID: 31849521
  7. 7

    Laparoscopic treatment of a solitary fibrous tumor originating in the cystic plate.

    Kumagai Y, Fujioka S, Misawa T, et al.

    Surgical case reports 2018; (4(1)):150 doi:10.1186/s40792-018-0556-7.

    PMID: 30594949
  8. 8

    Doege-Potter syndrome associated to metastatic solitary fibrous tumor.

    Andrade MO, de Sousa NDC, do Amaral PS, et al.

    Autopsy & case reports 2022; (12()):e2021412 doi:10.4322/acr.2021.412.

    PMID: 36569984
  9. 9

    Doege-Potter Syndrome; A Case of Solitary Fibrous Pleura Tumor Associated with Severe Hypoglycemia: A Case Report in Internal Medicine.

    Castaldo V, Domenici D, Biscosi MV, et al.

    Endocrine, metabolic & immune disorders drug targets 2023; (23(12)):1562-1569 doi:10.2174/1871530323666230623112047.

    PMID: 37357513
  10. 10

    A rare case of Doege-Potter syndrome: Anesthesia considerations for the surgical removal of a benign solitary lung fibrous tumor.

    Indragandhi J, Krishnaprabu R

    Saudi journal of anaesthesia 2025; (19(3)):422-424 doi:10.4103/sja.sja_626_24.

    PMID: 40642653
  11. 11

    [Rare cause of recurrent hypoglycemia].

    Barmpa I, Chatzitomaris A, Lüngen EM, Lobmann R

    Innere Medizin (Heidelberg, Germany) 2025; (66(8)):860-862 doi:10.1007/s00108-025-01889-2.

    PMID: 40167753
  12. 12

    Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.

    Jannin A, Espiard S, Benomar K, et al.

    Annales d'endocrinologie 2019; (80(1)):21-25 doi:10.1016/j.ando.2018.01.005.

    PMID: 29555080
  13. 13

    Doege-Potter Syndrome: A Solitary Fibrous Tumor Causing Non-Islet Cell Tumor Hypoglycemia.

    Sheikh K, Mody A, Haynes AB, Kumar P

    JCEM case reports 2024; (2(2)):luae017 doi:10.1210/jcemcr/luae017.

    PMID: 38405103
  14. 14

    A rare solitary fibrous tumor in the ischiorectal fossa: a case report.

    Morikawa K, Takenaga S, Masuda K, et al.

    Surgical case reports 2018; (4(1)):126 doi:10.1186/s40792-018-0533-1.

    PMID: 30284069
  15. 15

    MR Imaging Characteristics of Solitary Fibrous Tumors of the Orbit : Case Series of 18 Patients.

    Ziegenfuß C, van Landeghem N, Meier C, et al.

    Clinical neuroradiology 2024; (34(3)):605-611 doi:10.1007/s00062-024-01400-8.

    PMID: 38456912
  16. 16

    Malignant intracranial solitary fibrous tumor: A case report and literature review.

    Nhung TH, Minh VL, Lam NL, et al.

    Radiology case reports 2023; (18(5)):2014-2018 doi:10.1016/j.radcr.2023.02.064.

    PMID: 37033688
  17. 17

    Intradural-Extramedullary Solitary Fibrous Tumor/Hemangiopericytoma with a Negative Result on Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography.

    Tomomatsu Y, Iizuka Y, Mieda T, et al.

    Case reports in orthopedics 2019; (2019()):3926903 doi:10.1155/2019/3926903.

    PMID: 31885980
  18. 18

    Role of Immunohistochemistry in the Diagnosis of Solitary Fibrous Tumor, a Review.

    Geramizadeh B, Marzban M, Churg A

    Iranian journal of pathology 2016; (11(3)):195-203.

    PMID: 27799967
  19. 19

    [Solitary fibrous tumor/hemangiopericytoma].

    Teranishi Y, Hongou H, Miyawaki S, Saito N

    No shinkei geka. Neurological surgery 2022; (50(1)):141-149 doi:10.11477/mf.1436204539.

    PMID: 35169094
  20. 20

    The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior.

    Tariq MU, Din NU, Abdul-Ghafar J, Park YK

    Diagnostic pathology 2021; (16(1)):32 doi:10.1186/s13000-021-01095-2.

    PMID: 33879215
  21. 21

    Solitary fibrous tumor of the brain: A report of 3 cases.

    Chadha P, Durga G, Sharma A, et al.

    Oncology letters 2024; (28(4)):488 doi:10.3892/ol.2024.14621.

    PMID: 39185491
  22. 22

    A case of solitary fibrous tumor/hemangiopericytoma in the central nervous system with papillary morphology.

    Cao L, Zhang X, Wang Y, et al.

    Neuropathology : official journal of the Japanese Society of Neuropathology 2019; (39(2)):141-146 doi:10.1111/neup.12541.

    PMID: 30864263
  23. 23

    A Rare Case of Myxoid Solitary Fibrous Tumor of the Upper Lip: The Key Role of STAT6 in Diagnosis.

    Kahn B, Ceci FM, Yousefian F, et al.

    Cureus 2025; (17(3)):e81510 doi:10.7759/cureus.81510.

    PMID: 40308427

This guide explains the symptoms and diagnostic process for Solitary Fibrous Tumor (SFT) for educational purposes. Always consult your oncologist or medical team for advice regarding your specific diagnosis and care plan.

Stay up to date

Get notified when new research about Solitary Fibrous Tumor (SFT) is published.

No spam. Unsubscribe anytime.